Anticoagulation: Clinical Trials

1 trial for Anticoagulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Anticoagulation: new trials by email Literature Review of Anticoagulation trials Research Report on Anticoagulation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Nafamostat Mesylate for VV-ECMO Anticoagulation
Nafamostat Mesylate, Unfractionated Heparin - Critical Illness, Anticoagulation
Phase 2UnknownXiaobo Yang, MD402022-12-202023-02-15

Narrower conditions

Critical Illness (1)

Broader conditions

Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Heparin (1)  ·  nafamostat (1)

Sponsors

Xiaobo Yang, MD (1)

Countries

China (1)